Method for inducing directional differentiation of ips pluripotent stem cells to neural stem cells
Through the multi-stage culture medium scheme, resveratrol, ginseng saponin Rg3 and DHA are used to synergistically induce the directional differentiation of IPS pluripotent stem cells to neural stem cells, solving the problems of low efficiency and harsh conditions in the existing technology, and achieving high efficiency Neural stem cell induced culture has wide application prospects.
Patent Information
- Application Number
- CN202411157436.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-22
- Publication Date
- 2024-11-08
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art has problems of low efficiency and harsh conditions in inducing the directional differentiation of IPS pluripotent stem cells to neural stem cells, and has not yet effectively solved the problems of stem cells in vitro culture and directional differentiation.
Multi-stage culture medium scheme was adopted to induce differentiation at different stages using resveratrol, ginseng saponin Rg3 and DHA at different stages, and the differentiation efficiency was improved through the synergistic effect of antioxidant, neuroprotection and cell membrane components.
It has achieved efficient directed differentiation of IPS pluripotent stem cells, with a differentiation rate of nearly 99%, simple methods, wide sources of raw materials, mild conditions, and broad application prospects.
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of stem cells, and in particular to a method for inducing IPS pluripotent stem cells to differentiate into neural stem cells. Background Art
[0002] Neural stem cells are multipotent cells in the central nervous system that have the ability to self-renew and differentiate into mature brain cells. In 1992, Rynolds et al. first isolated neural stem cells from the striatum of adult rats. They can continue to proliferate in vitro and have the potential to differentiate into neurons, astrocytes and oligodendrocytes. Subsequently, multipotent stem cells were also isolated from the spinal cord, cerebellum, olfactory bulb, lateral ventricle, hippocampus and striatum. In 1998, Erikson et al. confirmed that neural stem cells also exist in the adult brain.
[0003] The establishment of in vitro stem cell isolation, expansion and differentiation technology and the realization of lateral differentiation of stem cells between different germ layers provide new strategies for the treatment of central nervous system damage, neurodegenerative diseases or inherited metabolic diseases, neurodegenerative diseases, brain tumors and cerebrovascular diseases. At present, stem cell therapy, as a new biological treatment method, is mainly developed and researched in the following aspects: first, direct cell transplantation for the dual effects of cell replacement therapy and gene therapy; second, through the study of growth factors and cytokines, endogenous stem cells are induced to proliferate and differentiate, and perform nerve self-repair.
[0004] The clinical application of stem cells is still immature. There is an urgent need to deepen the understanding of the biological characteristics of stem cells and solve problems such as maintaining the strong proliferation ability of stem cells cultured in vitro and inducing the directed differentiation of stem cells, as well as understanding the factors that control and influence the diversified transformation pathways of neural stem cells into neuronal cells. Summary of the invention
[0005] The purpose of the present invention is to propose a method for inducing directional differentiation of iPS pluripotent stem cells into neural stem cells. The method is simple, has a wide source of raw materials, and is mild under mild conditions. It can induce directional differentiation of iPS pluripotent stem cells into neural stem cells, can achieve the induced culture of neural stem cells, and has broad application prospects.
[0006] The technical solution of the present invention is achieved in this way:
[0007] The present invention provides a method for inducing IPS pluripotent stem cells to differentiate into neural stem cells, comprising the following steps:
[0008] S1. Inoculate the human iPS cell line in a culture dish covered with matrix gel, culture, change the medium every day, subculture once every 6-7 days, and obtain passage cells after 4-6 subcultures;
[0009] S2. The passaged cells were inoculated into a culture dish covered with matrix gel for culture. Culture medium 1 was laid on days 0-3, replaced with culture medium 2 on days 4-6, replaced with culture medium 3 on days 7-10, and the cells were collected on day 11 to obtain neural stem cells.
[0010] As a further improvement of the present invention, the inoculation amount of the human iPS cell line in step S1 is 2-3×10 4 Cells / cm 2 .
[0011] As a further improvement of the present invention, the culture conditions in step S1 are 36-38° C., 5% CO 2 cell culture incubator.
[0012] As a further improvement of the present invention, the culture medium in step S1 is mTeSRTM1 stem cell complete culture medium.
[0013] As a further improvement of the present invention, the inoculation amount of the passaged cells in step S2 is 1-2×10 6 Cells / cm 2 .
[0014] As a further improvement of the present invention, the culture medium 1 in step S2 is mTeSRTM1 stem cell complete culture medium containing 1-2 wt % resveratrol.
[0015] As a further improvement of the present invention, the culture medium 2 in step S2 is a complete mTeSRTM1 stem cell culture medium containing 1-2wt% resveratrol and 1.5-2.5wt% ginsenoside Rg3.
[0016] As a further improvement of the present invention, the culture medium 3 in step S2 is a complete mTeSRTM1 stem cell culture medium containing 1-2wt% resveratrol, 0.2-0.4wt% DHA and 1.5-2.5wt% ginsenoside Rg3.
[0017] As a further improvement of the present invention, the culture conditions in step S2 are 36-38° C., 5% CO 2 cell culture incubator.
[0018] The present invention has the following beneficial effects:
[0019] The present invention adopts a multi-stage culture medium for culture, wherein resveratrol is used for antioxidant induction in the first stage, and ginsenoside Rg3 and resveratrol are used for synergistic induction in the second stage. Ginsenoside Rg3 is a diol ginsenoside, which belongs to a rare saponin and has neuroprotective and repairing effects on many nervous system diseases such as Parkinson's disease, Alzheimer's disease, and stroke. In the third stage, DHA, ginsenoside Rg3 and resveratrol are used for synergistic induction. DHA is an important component of brain cell membranes, participates in the formation and development of brain cells, and plays an important role in the extension of nerve cell axons and the formation of new protrusions. The synergistic effect of multiple agents can significantly improve the induction differentiation efficiency, and the differentiation rate is close to 99%.
[0020] The method of the invention is simple, has a wide source of raw materials, and is mild under mild conditions. It can induce ips pluripotent stem cells to differentiate into neural stem cells, can achieve the induced culture of neural stem cells, and has broad application prospects. DETAILED DESCRIPTION
[0021] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0022] Example 1
[0023] This embodiment provides a method for inducing iPS pluripotent stem cells to differentiate into neural stem cells, comprising the following steps:
[0024] S1. Inoculate human iPS cell lines in a culture dish covered with matrix gel at a seeding volume of 2×10 4 Cells / cm 2 , cultured in a 36°C, 5% CO2 cell culture incubator, changing the medium every day, subculturing once every 6-7 days, and obtaining passage cells after 4-6 subculturings;
[0025] The culture medium is mTeSRTM1 stem cell complete medium;
[0026] S2. The subcultured cells were inoculated in a culture dish covered with matrix gel at a seeding volume of 1×10 6 Cells / cm 2 , cultured in a cell culture incubator at 36°C and 5% CO2, culture medium 1 was laid on days 0-3, replaced with culture medium 2 on days 4-6, replaced with culture medium 3 on days 7-10, and cells were collected on day 11 to obtain neural stem cells;
[0027] The culture medium 1 is mTeSRTM1 stem cell complete culture medium containing 1wt% resveratrol;
[0028] The culture medium 2 is mTeSRTM1 stem cell complete culture medium containing 1wt% resveratrol and 1.5wt% ginsenoside Rg3;
[0029] The culture medium 3 is a complete mTeSRTM1 stem cell culture medium containing 1 wt% resveratrol, 0.2 wt% DHA and 1.5 wt% ginsenoside Rg3.
[0030] Example 2
[0031] This embodiment provides a method for inducing iPS pluripotent stem cells to differentiate into neural stem cells, comprising the following steps:
[0032] S1. The human iPS cell line was inoculated in a culture dish covered with matrix gel at a seeding volume of 3×10 4 Cells / cm 2 , cultured in a 38°C, 5% CO2 cell culture incubator, changing the medium every day, subculturing once every 6-7 days, and obtaining passage cells after 4-6 subculturings;
[0033] The culture medium is mTeSRTM1 stem cell complete medium;
[0034] S2. The subcultured cells were inoculated in a culture dish covered with matrix gel at a seeding volume of 2×10 6 Cells / cm 2 , cultured in a cell culture incubator at 38°C and 5% CO2, culture medium 1 was laid on days 0-3, replaced with culture medium 2 on days 4-6, replaced with culture medium 3 on days 7-10, and cells were collected on day 11 to obtain neural stem cells;
[0035] The culture medium 1 is mTeSRTM1 stem cell complete culture medium containing 2 wt% resveratrol;
[0036] The culture medium 2 is a complete mTeSRTM1 stem cell culture medium containing 2 wt% resveratrol and 2.5 wt% ginsenoside Rg3;
[0037] The culture medium 3 is a complete mTeSRTM1 stem cell culture medium containing 2 wt % resveratrol, 0.4 wt % DHA and 2.5 wt % ginsenoside Rg3.
[0038] Example 3
[0039] This embodiment provides a method for inducing iPS pluripotent stem cells to differentiate into neural stem cells, comprising the following steps:
[0040] S1. The human iPS cell line was inoculated in a culture dish covered with matrix gel at a seeding volume of 2.5×10 4 Cells / cm 2, cultured in a 37°C, 5% CO2 cell culture incubator, changing the medium every day, subculturing once every 6-7 days, and obtaining passage cells after 4-6 subculturings;
[0041] The culture medium is mTeSRTM1 stem cell complete medium;
[0042] S2. The subcultured cells were inoculated in a culture dish covered with matrix gel at a seeding volume of 1.5×10 6 Cells / cm 2 , cultured in a cell culture incubator at 37°C and 5% CO2, culture medium 1 was laid on days 0-3, replaced with culture medium 2 on days 4-6, replaced with culture medium 3 on days 7-10, and cells were collected on day 11 to obtain neural stem cells;
[0043] The culture medium 1 is mTeSRTM1 stem cell complete culture medium containing 1.5wt% resveratrol;
[0044] The culture medium 2 is a complete mTeSRTM1 stem cell culture medium containing 1.5 wt% resveratrol and 2 wt% ginsenoside Rg3;
[0045] The culture medium 3 is a complete mTeSRTM1 stem cell culture medium containing 1.5 wt % resveratrol, 0.3 wt % DHA and 2 wt % ginsenoside Rg3.
[0046] Comparative Example 1
[0047] Compared with Example 3, the difference is that medium 1 is used on days 0-10.
[0048] Comparative Example 2
[0049] Compared with Example 3, the difference is that medium 2 is used on days 0-10.
[0050] Comparative Example 3
[0051] Compared with Example 3, the difference is that medium 3 is used on days 0-10.
[0052] Test Example 1 Flow cytometer detection of cell cycle
[0053] The neural stem cells prepared in Example 1-3 and Comparative Example 1-3 on the 4th day of the 3rd generation culture were respectively taken, and the normal human neural stem cells were selected as the control group, digested into a single cell suspension, washed twice with PBS, fixed with 70% ethanol by volume, incubated at 4°C overnight, washed twice with PBS, digested with 100 μL RNase, and then added with 0.5 mL PI dye, incubated at 4°C for 30 minutes, and the cell cycle was detected by flow cytometry, and the proliferation index (PI) was calculated according to the formula = [(S+G2 / M) / (G0 / G1+S+G2 / M)]×100%. The results are shown in Table 1.
[0054] Table 1
[0055] Group G0 / G1(%) S(%) G2 / M(%) PI(%) Control group 45.25 24.67 30.08 54.75 Example 1 28.14 46.32 25.54 71.86 Example 2 29.04 46.98 23.98 70.96 Example 3 28.67 47.09 24.24 71.33 Comparative Example 1 34.21 40.12 25.67 65.79 Comparative Example 2 35.87 39.57 24.56 64.13 Comparative Example 3 33.74 38.79 27.47 66.26
[0056] As can be seen from the above table, the neural stem cells prepared in Examples 1-3 of the present invention have more S-phase cells and higher PI values.
[0057] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for inducing ips pluripotent stem cells to differentiate into neural stem cells, characterized in that: The following steps are involved: S1. Inoculate the human iPS cell line in a culture dish covered with matrix gel, culture, change the medium every day, subculture once every 6-7 days, and obtain passage cells after 4-6 subcultures; S2. The passaged cells were inoculated into a culture dish covered with matrix gel for culture. Culture medium 1 was laid on days 0-3, replaced with culture medium 2 on days 4-6, replaced with culture medium 3 on days 7-10, and the cells were collected on day 11 to obtain neural stem cells.
2. The method according to claim 1, characterized in that The inoculation volume of the human iPS cell line in step S1 is 2-3×10 4 Cells / cm 2 .
3. The method according to claim 1, characterized in that The culture conditions in step S1 are 36-38° C., 5% CO 2 cell culture incubator.
4. The method according to claim 1, characterized in that The culture medium in step S1 is mTeSRTM1 stem cell complete culture medium.
5. The method according to claim 1, characterized in that The inoculation volume of the passaged cells in step S2 is 1-2×10 6 Cells / cm 2 .
6. The method according to claim 1, characterized in that The culture medium 1 in step S2 is mTeSRTM1 stem cell complete culture medium containing 1-2 wt % resveratrol.
7. The method according to claim 1, characterized in that The culture medium 2 in step S2 is a complete mTeSRTM1 stem cell culture medium containing 1-2 wt % resveratrol and 1.5-2.5 wt % ginsenoside Rg3.
8. The method according to claim 1, characterized in that The culture medium 3 in step S2 is a complete mTeSRTM1 stem cell culture medium containing 1-2wt% resveratrol, 0.2-0.4wt% DHA and 1.5-2.5wt% ginsenoside Rg3.
9. The method according to claim 1, characterized in that: The culture conditions in step S2 are 36-38° C., 5% CO 2 cell culture incubator.
Citation Information
Patent Citations
Novel serum-free medium for inducing neural stem cells and application of novel serum-free medium
CN108315301A
Traditional Chinese medicine composition, culture medium and method for promoting differentiation of pluripotent stem cells into neural stem cells
CN117264893A
Neurogenesis screening method and uses thereof
US20140179775A1
Cited By
Method for induced directional differentiation of iPS pluripotent stem cells into neural stem cells and application
CN119432745A
